Drugs / SanaCutan Basiscreme
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04398758 | Jul 2020 → Dec 2023 | atopic eczema | Infectopharm Arzneimittel GmbH | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SanaCutan Basiscreme | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04398758 ↗ |
| Route | Topical | “for twice daily application on the whole body (eyes and mucous membranes have to be omitted)” NCT04398758 ↗ |